Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRKS00027537Phase 4Recruiting
Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) comparing Baricitinib monotherapy, Baricitinib plus methotrexate and Etanercept plus methotrexate (3 arms). Started Mar 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on DRKS00027537.